The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
Open accessAbstract
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor cells with the ability to proliferate without restraint, to invade through tissue boundaries, and to survive in foreign microenvironments. Recent studies have revealed that integrin signaling drives multiple stem cell functions, including tumor initiation, epithelial plasticity, metastatic reactivation, and resistance to oncogene- and immune-targeted therapies. Here, we discuss the mechanisms leading to the deregulation of integrin signaling in cancer and its various consequences. We place emphasis on novel functions, determinants of context dependency, and mechanism-based therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–240 of 240
Naci, D., Azreq, M.-A. E., Chetoui, N., Lauden, L., Sigaux, F., Charron, D. J., Al‐Daccak, R., & Aoudjit, F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349365 · Cited by 106
Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
Ming, X.-Y., Fu, L., Zhang, L.-Y., Qin, Y.-R., Cao, T.-T., Chan, K. W., Ma, S., Xie, D., & Guan, X. (2016) · Nature Communications · doi:10.1038/ncomms13568 · Cited by 103
Parvani, J. G., Galliher-Beckley, A. J., Schiemann, B. J., & Schiemann, W. P. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0776 · Cited by 102
Zoni, E., van der Horst, G., van de Merbel, A. F., Chen, L., Rane, J. K., Pelger, R. C. M., Collins, A. T., Visakorpi, T., Snaar-Jagalska, E. B., Maitland, N. J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2155 · Cited by 100
PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes
Garmy-Susini, B. H., Avraamides, C. J., Desgrosellier, J. S., Schmid, M. C., Foubert, P., Ellies, L. G., Lowy, A. M., Blair, S. L., VandenBerg, S. R., Datnow, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219603110 · Cited by 99
Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
Desgrosellier, J. S., Lesperance, J., Seguin, L., Gozo, M. C., Kato, S., Franovic, A., Yebra, M., Shattil, S. J., & Cheresh, D. A. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.06.005 · Cited by 97
Zhang, J., Niu, G., Lang, L., Li, F., Fan, X., Yan, X., Yao, S., Yan, W., Huo, L., Chen, L., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.177048 · Cited by 93
Okada, T., Lee, A. Y., Qin, L., Agaram, N. P., Mimae, T., Shen, Y., O’Connor, R., López-Lago, M. A., Craig, A. J., Miller, M. L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1481 · Cited by 92
β4 Integrin signaling induces expansion of prostate tumor progenitors
Yoshioka, T., Otero, J. A., Chen, Y., Kim, Y. M., Koutcher, J. A., Satagopan, J. M., Reuter, V., Carver, B. S., de Stanchina, E., Enomoto, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60720 · Cited by 90
Self-citationReuter, J. A., Ortiz-Urda, S., Kretz, M., Garcia, J., Scholl, F. A., Pasmooij, A. M. G., Cassarino, D., Chang, H. Y., & Khavari, P. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.002 · Cited by 88
Bogorad, R. L., Yin, H., Zeigerer, A., Nonaka, H., Ruda, V. M., Zerial, M., Anderson, D. G., & Koteliansky, V. (2014) · Nature Communications · doi:10.1038/ncomms4869 · Cited by 86
Ross, J., Huh, D., Earnest-Noble, L. B., & Tavazoie, S. F. (2015) · Nature Cell Biology · doi:10.1038/ncb3148 · Cited by 85
Urokinase Receptor and Integrin Interactions
Kugler, M. C., Wei, Y., & Chapman, H. A. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454658 · Cited by 84
PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion
Mense, S. M., Barrows, D., Hodakoski, C., Steinbach, N., Schoenfeld, D. A., Su, W., Hopkins, B. D., Su, T., Fine, B. M., Hibshoosh, H. H., et al. (2015) · Science Signaling · doi:10.1126/scisignal.2005840 · Cited by 81
The LKB1-AMPK Pathway—Friend or Foe in Cancer?
Hardie, D. G. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.009 · Cited by 81
High‐resolution in vivo imaging of breast cancer by targeting the pro‐invasive integrin αvβ6
Saha, A., Ellison, D. H., Thomas, G. J., Vallath, S., Mather, S. J., Hart, I. R., & Marshall, J. F. (2010) · The Journal of Pathology · doi:10.1002/path.2745 · Cited by 78
Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells
Dickreuter, E., Eke, I., Krause, M., Borgmann, K., van Vugt, M. A. T. M., & Cordes, N. (2015) · Oncogene · doi:10.1038/onc.2015.212 · Cited by 77
WANG, H., HUNG, Y., Su, C., Peng, S., Guo, Y., LAI, M., LIU, C., & HSU, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.015 · Cited by 75
Integrin‐associated proteins as potential therapeutic targets
Cantor, J. M., Ginsberg, M. H., & Rose, D. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00640.x · Cited by 75
Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling
Goel, H. L., Pursell, B. M., Standley, C., Fogarty, K. E., & Mercurio, A. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.094433 · Cited by 73
Endothelial α3β1-Integrin Represses Pathological Angiogenesis and Sustains Endothelial-VEGF
da Silva, R. G., Tavora, B., Robinson, S. D., Reynolds, L. E., Szekeres, C. K., Lamar, J. M., Batista, S., Kostourou, V., Germain, M., Reynolds, A. R., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100043 · Cited by 65
Distinct FAK Activities Determine Progenitor and Mammary Stem Cell Characteristics
Luo, M., Zhao, X., Chen, S., Liu, S., Wicha, M. S., & Guan, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1351 · Cited by 62
Fafílek, B., Bálek, L., Bosakova, M. K., Vařecha, M., Niţă, A., Gregor, T., Gudernová, I., Křenová, J., Ghosh, S., Piskáček, M., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aap8608 · Cited by 61
Hemostatic factors, innate immunity and malignancy
Degen, J. L., & Palumbo, J. S. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70143-3 · Cited by 59
FAK Mediates a Compensatory Survival Signal Parallel to PI3K-AKT in PTEN-Null T-ALL Cells
You, D., Xin, J., Volk, A. G., Wei, W., Schmidt, R., Scurti, G. M., Nand, S., Breuer, E.-K. Y., Kuo, P. C., Breslin, P., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.056 · Cited by 57
Tumor Angiogenesis in the Absence of Fibronectin or Its Cognate Integrin Receptors
Murphy, P. A., Begum, S., & Hynes, R. O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120872 · Cited by 56
Raymond, K., Kreft, M., Song, J., Janssen, H., & Sonnenberg, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0720 · Cited by 56
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Iwanicki, M., Chen, H., Iavarone, C., Zervantonakis, I. K., Muranen, T. E., Novak, M., Ince, T. A., Drapkin, R., & Brugge, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.86829 · Cited by 56
FAK-heterozygous mice display enhanced tumour angiogenesis
Kostourou, V., Lechertier, T., Reynolds, L. E., Lees, D. M., Baker, M., Jones, D. T., Tavora, B., Ramjaun, A. R., Birdsey, G. M., Robinson, S. D., et al. (2013) · Nature Communications · doi:10.1038/ncomms3020 · Cited by 49
Slack‐Davis, J. K., Hershey, E. D., Theodorescu, D., Frierson, H. F., & Parsons, J. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0262 · Cited by 48
An Activating β1 Integrin Mutation Increases the Conversion of Benign to Malignant Skin Tumors
Ferreira, M. M., Fujiwara, H., Morita, K., & Watt, F. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3051 · Cited by 43
Rys, J. P., DuFort, C. C., Monteiro, D. A., Baird, M. A., Osés-Prieto, J. A., Chand, S., Burlingame, A. L., Davidson, M. W., & Alliston, T. N. (2015) · eLife · doi:10.7554/elife.09300 · Cited by 42
Paradžik, M., Humphries, J. D., Stojanović, N., Nestić, D., Majhen, D., Dekanić, A., Samaržija, I., Sedda, D., Weber, I. T., Humphries, M. J., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00125 · Cited by 41
β 1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination
Ahmed, K. M., PANDITA, R. K., Singh, D. K., Hunt, C. R., & Pandita, T. K. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00672-17 · Cited by 40
β1 integrin cytoplasmic tyrosines promote skin tumorigenesis independent of their phosphorylation
Meves, A., Geiger, T., Zanivan, S. R., DiGiovanni, J., Mann, M., & Fässler, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105689108 · Cited by 39
Tod, J., Hanley, C. J., Morgan, M. R., Rucka, M., Mellows, T., Lopez, M. A., Kiely, P., Moutasim, K. A., Frampton, S. J., Sabnis, D. H., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4923 · Cited by 34
Keat, N., Kenny, J. D., Chen, K., Onega, M., Garman, N., Slack, R. J., Parker, C. A., Lumbers, R. T., Hallett, W., Saleem, A., et al. (2018) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.117.203547 · Cited by 31
Gao, Q., Lei, F., Zeng, Q., Gao, Z., Niu, P., Junnan, Ning, Li, J., & Zhang, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.40787 · Cited by 30
Lahlou, H., Sanguin‐Gendreau, V., Frame, M. C., & Muller, W. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3131 · Cited by 29
Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors
Sharma, R., Kallur, K., Ryu, J. S., Parameswaran, R., Lindman, H., Avril, N. E., Gleeson, F. V., Lee, J. D., Lee, K.-H., O'Doherty, M. J., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158253 · Cited by 26
Cited by
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
Metastatic colorectal cancer: mechanisms and emerging therapeutics
Shin, A. E., Giancotti, F. G., & Rustgi, A. K. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.01.003 · Cited by 669
Self-citationCell adhesion in cancer: Beyond the migration of single cells
Janiszewska, M., Primi, M. C., & Izard, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007759 · Cited by 646
Mechanical regulation of bone remodeling
Wang, L., You, X., Zhang, L., Zhang, C., & Zou, W. (2022) · Bone Research · doi:10.1038/s41413-022-00190-4 · Cited by 641
Metadata
- Authors
- Cooper, J., & Giancotti, F. G.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 35
- Issue
- 3
- Pages
- 347-367
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2920879064
- Cited by
- 945
- References
- 240
- FWCI
- 56.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.